Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

BACKGROUND: Current guidelines for acute coronary syndrome recommend clopidogrel for an optimal period of 12 months in order to reduce the risk of reinfarction and mortality. Premature clopidogrel discontinuation has been associated with higher rates of rehospitalization, coronary stent thrombosis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Page, Robert Lee, Ghushchyan, Vahram, Allen, Richard R, Roper, Lisa, Beck, Don, Jonathan, Bamrom H, Frech-Tamas, Feride, Chan, Wing, McQueen, R Brett, Nair, Kavita V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402012/
https://www.ncbi.nlm.nih.gov/pubmed/22826644
http://dx.doi.org/10.2147/DHPS.S32473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402012/
https://www.ncbi.nlm.nih.gov/pubmed/22826644
http://dx.doi.org/10.2147/DHPS.S32473

Ejemplares similares